AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Intercos

Investor Presentation May 7, 2025

4306_rns_2025-05-07_13588adc-4424-486d-8d0f-38d4f78e2f0b.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

IMPORTANT NOTICE

This presentation might contain certain forward-looking statements that reflect the Company's management current views with respect to future events and financial and operational performance of the Company and its subsidiaries.

This presentations is being furnished to you solely for your information and may not be reproduced or redistributed to any other person. These forward-looking statements are based on Intercos current expectations and projections about future events. Because these forward-looking statements are subject to risks and uncertainties, actual future results or performance may differ materially from those expressed in or implied by these statements due to any number of different factors, many of which are beyond the ability of Intercos to control or estimate. You are cautioned not to place undue reliance on the forward-looking statements contained herein which are made only as of the date of this presentation. Intercos does not undertake any obligation to publicly release any updates or revisions to any forward-looking statements to reflect events or circumstances after the date of this presentation. Stefano Zanelli, the Manager in charge of preparing the corporate accounting documents, declares that, pursuant to art. 154-bis, paragraph 2, of the Legislative Decree no.58 of February 24, 1998,

Any reference to past performance or trends or activities of Intercos shall not be taken as a representation or indication that such performance, trends or activities continue in the future.

This presentation does not constitute an offer to sell or the solicitation of an offer to buy the Group's securities, nor shall the document form the basis of or be relied on in connection with any contract or investment decision relating thereto, or constitute a recommendation regarding the securities of Intercos.

Intercos securities referred to in this document have not been and will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

the accounting information contained herein correspond to document results, books and accounting records.

1Q25 Results Overview

  • 1Q25 Net Sales amounted to €250.8m (+13.4% at reported FX, and +13.1% at constant FX), increasing by +€29.7m compared to 1Q24. Despite a challenging start of the growth, with multinationals recovering well vs. 1Q24.
  • 1Q25 Adjusted EBITDA was equal to €29.3m (+40.6% vs. 1Q24), growing by +€8.4m vs. LY. The growth was driven by higher sales but even more by higher profitability, which grew by +225Bps vs. 1Q24. Last Twelve Months Adj. EBITDA surpassed €150m.
  • 31Mar25 Net Debt stood at €126.9m, or €84.4m once the IFRS16 impact is excluded, reflecting a slight increase mainly due to the expansion plans currently undergoing. Leverage ratio (Net Debt on LTM Adjusted EBITDA) amounted to 0.84x, well below the 1x threshold.

-

-

-

Outlook & Guidance

Outlook & Guidance
Topic Update
Where we stand Innovation
continues
to
be
central
to
our
business
model
and
it
ensures
the
unique
position
of
our
Group
in
the
global
Beauty
market.
This
is
all
the
more
critical
in
a
context
of
general
market
softness
as
brands
tend
to
beef
up
their
innovation
pipeline
to
sustain
market
shares.
In
addition
to
this,
diversification
is
another
pillar
of
our
Group,
becoming
more
and
more
important
nowadays.
During
Cosmoprof,
the
biggest
Beauty
fair
worldwide,
the
Group
had
approx.
450
meetings
with
customers,
interested
in
discovering
new
trends
and
new
formulations
proposed
by
Intercos
for
the
years
to
come.
We
continue
to
develop
new
formulations
and
new
patents,
developed
regionally
for
the
local
markets
in
which
we
and
our
clients
operate.
Current Scenario
and our view
In
a
context
of
trade
wars
triggered
by
tariff
policies,
Intercos
continues
to
benefit
from
the
high
level
of
diversification
that
sets
the
Group
apart:
with
two
manufacturing
plants
in
the
USA,
one
in
Brazil,
five
in
Italy,
one
in
Switzerland,
one
in
Poland,
one
in
India,
four
in
China,
and
one
in
South
Korea,
Intercos'
presence,
close
to
end
markets,
represents
a
natural
alternative
in
the
global
Beauty
landscape,
that
can
provide
innovation
to
clients
in
a
more
efficient
way.
We
believe
that,
in
the
current
environment,
the
Group's
widespread
geographic
footprint
will,
in
the
medium
term,
provide
strong
alternatives
for
the
supply
chains
of
Beauty
brands
around
the
world,
which
are
reasonably
expected
to
increase
the
outsourcing
production
for
products
to
be
launched
in
various
markets.
On
top
of
this,
main
part
of
Intercos'
direct
competition
won't
have
the
possibility
to
switch
production
from
one
plant
to
another
like
our
Group
can
do,
as
they
normally
leverage
on
a
regional
presence
only.
Updated FY25
Guidance
The
Group
confirms
therefore
the
FY25
Net
Sales
expected
to
increase
vs.
FY24
in
a
range
between
+5%/+7%
at
constant
FX,
also
thanks
to
the
good
order-in-take
development.

For the purpose of providing information in line with the performance analysis and control parameters of the Group, non-IFRS alternative performance measures are used by management to provide information for a better assessment of the results of operations and the financial position of the Group as described below. Such performance measures should not be interpreted as a substitute for the conventional performance measures established by IFRS. The details of the content of the alternative performance measures not arrived at directly from the financial statements are defined as follows: • EBITDA: is defined as the sum of profit for the year plus income taxes, financial income and expenses and the effects of the valuation of investments using the equity method net of

  • equity investments held for financial investment purposes and amortization, depreciation and write-downs.
  • Adjusted EBITDA: is given by EBITDA less items of a non-recurring nature, that is, by particularly significant events that are not in the ordinary course of business or that have no effect on cash flows and/or changes in equity.
  • Net indebtedness (cash) or net financial position/net debt: is given by the sum of current and non-current financial payables net of current and non-current financial receivables, including cash and cash equivalents.

Talk to a Data Expert

Have a question? We'll get back to you promptly.